Strategies to find new genes involved in drug metabolism

Current Opinion in Molecular Therapeutics

Volumn 3, Issue 6, 2001, Pages 579-584

  Sheffield, L J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Association; Candidate genes; Case control study; Genotype; Metabolic ratio; Pharmacogenomics; Whole genome scan

Indexed keywords

4 HYDROXYDEBRISOQUINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2D6; DEBRISOQUINE; FLUOXETINE; SPARTEINE;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG URINE LEVEL; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MOLECULAR GENETICS; PHARMACOGENOMICS; PHENOTYPE; SIDE EFFECT;

CYTOCHROME P-450 CYP2D6; GENETIC MARKERS; HUMANS; PHARMACOKINETICS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0035669996     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist?
2. Pharmacokinetics
3. Science, medicine, and the future: Pharmacogenetics
4. 'It's the genes stupid': Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism
5. The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions
6. Pharmacogenetics and the practice of medicine
7. Pharmacogenetics: The slow, the rapid and the ultrarapid
8. Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes
9. Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22
10. Chracterezation of the common genetic defect in humans deficient in debrisoquine metabolism
11. The human debrisquoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene and a pseudogene
12. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
13. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine
14. Pharmacogenetics
15. Cythochrome P450 Homepage
16. Human cytochrome P450 (CYP) allele nomenclature committee
17. Sequential tests or the detection of linkage
18. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
19. Searching for genetic determinants in the new millennium
20. The future of genetic studies of complex human diseases
21. Pharmacogenomics, ethnicity and susceptibility genes
22. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependant diabetes mellitus (IDDM)
23. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling
24. Tests and estimates of allelic association in complex inheritance
25. Case-control studies
26. Association mapping of disease loci, by use of pooled DNA genomic screen
27. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. II. Individual genotyping
28. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
29. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
30. Genetic dissection of complex traits in a high density SNP map era